Tech Company Financing Transactions
GeneWeave Biosciences Funding Round
Claremont Creek Ventures, private investors and XSeed Capital participated in a $12 million Series A capital raise for GeneWeave Biosciences. This venture round was announced on 3/1/2012.
Transaction Overview
Company Name
Announced On
3/1/2012
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Proceeds Purpose
Steve Tablak, the CEO of GeneWeave Biosciences, said the latest infusion of capital will be used to complete the development, validation and clearance of the initial test for the company's platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5941 Optical Ct. Bldg B
Los Gatos, CA 95138
USA
Los Gatos, CA 95138
USA
Phone
Website
Email Address
Overview
Our simple method of detecting bacterial DNA is paving the way for a new wave of gene-probing tests that are simple, robust, and highly adaptable to industry needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Tablak
Browse more venture capital transactions:
Prev: 3/1/2012: Mediamorph venture capital transaction
Next: 3/1/2012: Organovo venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs